Year: 2002
Type: review
Abstract: Selegiline, a selective inhibitor of monoamine oxidase-B (MAO-B), was one of the first adjunct therapies in clinical neurology. A retrospective analysis of data from patients with Parkinson's disease found a significant increase in survival in those treated with selegiline plus L-dopa compared with L-dopa alone. The mechanism of action of selegiline is complex and cannot be explained solely by its MAO-B inhibitory action. Pretreatment with selegiline can protect neurons against a variety of neurotoxins, such as 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP), 6-hydroxydopamine, N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4), methyl-beta-acetoxyethyl-2-chloroethylamine (AF64A), and 5,6-dihydroxyserotonin, which damage dopaminergic, adrenergic, cholinergic, and sertoninergic neurons, respectively. Selegiline produces an amphetamine-like effect, enhances the release of dopamine, and blocks the reuptake of dopamine. It stimulates gene expression of L-aromatic amino acid decarboxylase, increases striatal phenylethylamine levels, and activates dopamine receptors. Selegiline reduces the production of oxidative radicals, up-regulates superoxide dismutase and catalase, and suppresses nonenzymatic and iron-catalyzed autooxidation of dopamine. Selegiline compensates for loss of target-derived trophic support, delays apoptosis in serum-deprived cells, and blocks apoptosis-related fall in the mitochondrial membrane potential. Most of the aforementioned properties occur independently of selegiline's efficacy to inhibit MAO-B.
Source: Journal of Neuroscience Research
DOI: 10.1002/jnr.10148
Authors: M. Ebadi, S. Sharma, S. Shavali, H. El Refaey
Institution: University of North Dakota
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: selegiline, neuroprotection, monoamine oxidase B inhibition, Parkinson's disease, L-DOPA, neurotoxins, dopamine release, dopamine reuptake, aromatic L-amino acid decarboxylase, phenylethylamine, oxidative stress, superoxide dismutase, catalase, dopamine autoxidation, apoptosis, mitochondrial membrane potential, dopaminergic neurons
Open Access status: bronze
OpenAlex ID: W2080496794
